+33 1 76 70 47 90
/
creativ@creativ-ceutical.com
Home
Who We Are
About Us
Strategic Management Board
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Partnerships
Japan
Publications
News & Events
Careers
Contact
Home
Who We Are
About Us
Strategic Management Board
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Partnerships
Japan
Publications
News & Events
Careers
Contact
Cost-utility of secukinumab in Italian patients with moderate to severe plaque-type psoriasis
Home
Publications
Cost-utility of secukinumab in Italian patients with moderate to severe plaque-type psoriasis
Back Home
Cost-utility of secukinumab in Italian patients with moderate to severe plaque-type psoriasis
2017 Clinical Dermatolgy
D’Ausilio, A. | Aiello, A. | Esposito, M. | Graham, C. | Roccia, A. | Giunta, A. | Altomare, G. |
Volume: 5, Issue: 2, Pages: 65-72,
